Conduit Pharmaceuticals, Inc. is a disease agnostic life science company providing an efficient model for compound development. The company acquires assets that are Phase II-ready and seeks exits through third-party license deals following successful clinical trials.

Conduit Pharmaceuticals

Conduit Pharmaceuticals | 152 followers on LinkedIn. multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development

Dave Tapolczay

Partner at Thompson Hine LLP (Corporate & Securities) - Co-Chair of Public Companies Group, Chair Life Sciences Industry | Group Board Member

Faith Charles, JD

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Conduit Pharmaceuticals Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 9, 2024 1:22 AM	6c806d25
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 9, 2024 1:22 AM	b3c781ad
crunchbase trigger	general	Nov 9, 2024 1:22 AM	b2688503
crunchbase profile	general
li profile	general	Nov 9, 2024 1:22 AM	e7f904d3
translate crunchbase fundingrounds	general
peers	general	Nov 9, 2024 1:22 AM	5d556f7a
news basic	general	Nov 9, 2024 1:22 AM	a69a6357
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CDT

COM:CONDUITPHARMA

Conduit Pharmaceuticals

Last Close

0.11

22/11 21:00

Market Cap

21.78M

Beta: -

Volume Today

23.25M

Avg: -